“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy
Objective: Many Black breast cancer patients experience chemotherapy-induced peripheral neuropathy (CIPN). Our study assessed Black breast cancer patients’ questions about a biomarker test that can predict likelihood of CIPN. Methods: Nineteen Black women who were previous/current breast cancer pati...
Main Authors: | Katharine J. Head, Lisa R. Hayes, Nadia E. Miller, Safia Shakil, Casey L. Bales, Bryan P. Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | PEC Innovation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772628222001030 |
Similar Items
-
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
by: Hana Starobova, et al.
Published: (2017-05-01) -
Chemotherapy-Induced Peripheral Neuropathy: Pathophysiology, Diagnosis, and Treatment
by: Ica Justitia, et al.
Published: (2024-07-01) -
Chemotherapy-induced peripheral neuropathy: review for clinical practice
by: Delma Aurélia da Silva Simão, et al. -
Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment
by: Timothy F. Marshall, et al.
Published: (2017-12-01) -
Frequency of Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients in Sari Imam Khomeini Hospital
by: Ramin Shekarriz, et al.
Published: (2023-03-01)